Jenburkt-Pharma Stock/Share Prices, Buy and Sell Jenburkt-Pharma BSE Stocks

Market Snapshot

BSE Sensex: 49591.32 -0.31%
BSE 500: 19944.06 -0.11%
BSE 200: 6387.44 -0.16%
BSE 100: 15051.16 -0.24%
BSE Mid-Cap: 20762.17 -0.08%
BSE Small-Cap: 21596.85 0.69%
BANKEX: 36770.43 -0.82%
BSE IT Sector: 28078.95 0.56%
Nifty 50: 14834.85 -0.26%
Nifty 500: 12527.4 -0.11%
Nifty 200: 7793.3 -0.16%
Nifty 100: 15004.15 -0.21%
Nifty Midcap 100: 24505.7 0.18%
Nifty Small 100: 8559.1 0.47%
Nifty IT: 27367.05 0.81%
Nifty PSU Bank: 2191.25 2.09%

News:

CRISIL board to consider quart...
ICRA reaffirms ratings of Balr...
Trident bath linen production ...
Sands Capital hikes stake in J...
Dow, S&P 500 close at record h...

Jenburkt Pharmaceuticals Ltd BSE
Pharmaceuticals, Small Cap

Invest

09 Apr 2021 | 03:59 PM

404.70

0.90 (0.22%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

25.49%

Return (1Y)

Underperformed S&P BSE Sensex by 33.66%
More Volatile

3.26%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 1.95%
Not so consistent

5/12

Months

underperformed S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

500

304

News & Announcements

Jenburkt Pharmaceuticals standalone net profit rises 28.23% in the December 2020 quarter
63 days ago

Jenburkt Pharmaceuticals standalone net profit rises 28.23% in the December 2020 quarter

06 - Feb - 2021 12:00 AM | 63 days ago

Net profit of Jenburkt Pharmaceuticals rose 28.23% to Rs 5.95 crore in the quarter ended December 2020 as against Rs 4.64 crore during the previous quarter ended December 2019. Sales declined 5.27% to Rs 31.82 crore in the quarter ended December 2020 as against Rs 33.59 crore during the previous quarter ended December 2019.
Particulars Quarter Ended
Dec. 2020 Dec. 2019 % Var.
Sales 31.82 33.59 -5
OPM % 22.09 19.77 -
PBDT 7.96 7.33 9
PBT 7.45 6.67 12
NP 5.95 4.64 28
Powered by Capital Market - Live News
Jenburkt Pharmaceuticals to discuss results
75 days ago

Jenburkt Pharmaceuticals to discuss results

25 - Jan - 2021 12:00 AM | 75 days ago

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 February 2021.
Powered by Capital Market - Live News
Jenburkt Pharmaceuticals standalone net profit rises 2.16% in the September 2020 quarter
162 days ago

Jenburkt Pharmaceuticals standalone net profit rises 2.16% in the September 2020 quarter

30 - Oct - 2020 12:00 AM | 162 days ago

Net profit of Jenburkt Pharmaceuticals rose 2.16% to Rs 5.67 crore in the quarter ended September 2020 as against Rs 5.55 crore during the previous quarter ended September 2019. Sales declined 10.83% to Rs 30.48 crore in the quarter ended September 2020 as against Rs 34.18 crore during the previous quarter ended September 2019.
Particulars Quarter Ended
Sep. 2020 Sep. 2019 % Var.
Sales 30.48 34.18 -11
OPM % 23.52 21.71 -
PBDT 8.07 8.09 0
PBT 7.56 7.55 0
NP 5.67 5.55 2
Powered by Capital Market - Live News
Jenburkt Pharmaceuticals announces board meeting date
170 days ago

Jenburkt Pharmaceuticals announces board meeting date

22 - Oct - 2020 12:00 AM | 170 days ago

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 October 2020.
Powered by Capital Market - Live News

Price vs Volume

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2020	Dec. 2019	% Var.
Sales	31.82	33.59	-5
OPM %	22.09	19.77	-
PBDT	7.96	7.33	9
PBT	7.45	6.67	12
NP	5.95	4.64	28

Particulars	Quarter Ended
	Sep. 2020	Sep. 2019	% Var.
Sales	30.48	34.18	-11
OPM %	23.52	21.71	-
PBDT	8.07	8.09	0
PBT	7.56	7.55	0
NP	5.67	5.55	2

General Notifications

My Notifications

Research Notifications

Jenburkt Pharmaceuticals Ltd BSE Pharmaceuticals, Small Cap

404.70 0.90 (0.22%)

News & Announcements

Price vs Volume

Jenburkt Pharmaceuticals Ltd BSE
Pharmaceuticals, Small Cap

404.70

0.90 (0.22%)